Eton Pharmaceuticals ETON
NASDAQ ETON
$61.02 -0.46 (-0.75%)
At close: Aug 20, 2026 · 2:05 PM UTC

Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals (ETON) posted Other Non Operating Income of $1.2 million for Q4 2024, up 238.39% sequentially from -$831000.0 in Q4 2023, and up 238.39% YoY from $339847.1 in Q1 2024.

Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024) Analysis & Trends

Eton Pharmaceuticals has reported Other Non Operating Income for 4 years, with the latest figure at $1.2 million in Q4 2024.

  • Quarterly Other Non Operating Income rose 238.39% year-over-year to $1.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.2 million (up 3809.68% YoY) and the FY2025 annual result came in at -$424000.0, down 136.87% from the prior year.
  • Other Non Operating Income improved to $1.2 million in Q4 2024 per ETON's latest filing, from -$831000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $1.2 million in Q4 2024 and troughed at -$831000.0 in Q4 2023.
  • A 4-year average of $459200.0 and a median of $800000.0 in 2023 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2023 and 2024: Other Non Operating Income plunged 202.34% in 2023, then soared 238.39% in 2024.
  • Over 4 years, Other Non Operating Income stood at $365000.0 in 2021, then surged by 122.47% to $812000.0 in 2022, then slumped by 202.34% to -$831000.0 in 2023, then jumped by 238.39% to $1.2 million in 2024.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $1.2 million, -$831000.0, and $800000.0 for Q4 2024, Q4 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Eton Pharmaceuticals 1.69 Bn 1.66 Bn 25.41 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 1.15 Mn
Dec 31, 2023 -831,000.00
Jun 30, 2023 800,000.00
Dec 31, 2022 812,000.00
Jun 30, 2021 365,000.00